
Thanks to @escardio for inviting us to present Ripple AT+ as a late breaking clinical trial at #ESC2026. Ripple Mapping-guided isthmus ablation resulted in significantly reduced arrhythmia recurrence in pts undergoing AT ablation compared to conventional LAT-guided ablation. Thanks very much to all the investigators and research teams involved. @ImperialEP @LHCHFT @AndreaRussoEP @TobiasReichlin
🤔Can we improve outcomes in Atrial Tachycardia ablation? 🔸We presented the Ripple AT-plus RCT as a LBCT at #ESC2026 👇 🔸201 pts with AT from 8 UK EP centres. 🔸Ripple guided isthmus ablation had greater freedom from arrythmia recurrence at 12m Congrats @balrik & @LHCHFT



















